nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—ALB—Captopril—systemic scleroderma	0.14	0.237	CbGbCtD
Oxcarbazepine—ALB—Mycophenolate mofetil—systemic scleroderma	0.111	0.187	CbGbCtD
Oxcarbazepine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0889	0.15	CbGbCtD
Oxcarbazepine—ALB—Prednisone—systemic scleroderma	0.0884	0.149	CbGbCtD
Oxcarbazepine—CYP2C19—Prednisone—systemic scleroderma	0.0573	0.0968	CbGbCtD
Oxcarbazepine—ALB—Methotrexate—systemic scleroderma	0.0444	0.0749	CbGbCtD
Oxcarbazepine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0347	0.0585	CbGbCtD
Oxcarbazepine—CYP3A4—Prednisone—systemic scleroderma	0.0277	0.0468	CbGbCtD
Oxcarbazepine—Pain—Mycophenolic acid—systemic scleroderma	0.000232	0.00057	CcSEcCtD
Oxcarbazepine—Constipation—Mycophenolic acid—systemic scleroderma	0.000232	0.00057	CcSEcCtD
Oxcarbazepine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000569	CcSEcCtD
Oxcarbazepine—Weight decreased—Prednisone—systemic scleroderma	0.000231	0.000567	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000566	CcSEcCtD
Oxcarbazepine—Hyperglycaemia—Prednisone—systemic scleroderma	0.00023	0.000565	CcSEcCtD
Oxcarbazepine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000229	0.000562	CcSEcCtD
Oxcarbazepine—Hypotension—Lisinopril—systemic scleroderma	0.000229	0.000561	CcSEcCtD
Oxcarbazepine—Dizziness—Captopril—systemic scleroderma	0.000228	0.00056	CcSEcCtD
Oxcarbazepine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000228	0.000559	CcSEcCtD
Oxcarbazepine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000558	CcSEcCtD
Oxcarbazepine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000556	CcSEcCtD
Oxcarbazepine—Urticaria—Leflunomide—systemic scleroderma	0.000226	0.000555	CcSEcCtD
Oxcarbazepine—Abdominal pain—Leflunomide—systemic scleroderma	0.000225	0.000552	CcSEcCtD
Oxcarbazepine—Body temperature increased—Leflunomide—systemic scleroderma	0.000225	0.000552	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000224	0.000549	CcSEcCtD
Oxcarbazepine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000548	CcSEcCtD
Oxcarbazepine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000548	CcSEcCtD
Oxcarbazepine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000548	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000223	0.000547	CcSEcCtD
Oxcarbazepine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000547	CcSEcCtD
Oxcarbazepine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000222	0.000546	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000222	0.000545	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000222	0.000545	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000545	CcSEcCtD
Oxcarbazepine—Insomnia—Lisinopril—systemic scleroderma	0.000221	0.000543	CcSEcCtD
Oxcarbazepine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000542	CcSEcCtD
Oxcarbazepine—Vomiting—Captopril—systemic scleroderma	0.00022	0.000539	CcSEcCtD
Oxcarbazepine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000536	CcSEcCtD
Oxcarbazepine—Dyspnoea—Lisinopril—systemic scleroderma	0.000218	0.000535	CcSEcCtD
Oxcarbazepine—Rash—Captopril—systemic scleroderma	0.000218	0.000534	CcSEcCtD
Oxcarbazepine—Dermatitis—Captopril—systemic scleroderma	0.000218	0.000534	CcSEcCtD
Oxcarbazepine—Somnolence—Lisinopril—systemic scleroderma	0.000217	0.000533	CcSEcCtD
Oxcarbazepine—Headache—Captopril—systemic scleroderma	0.000216	0.000531	CcSEcCtD
Oxcarbazepine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000216	0.00053	CcSEcCtD
Oxcarbazepine—Dyspepsia—Lisinopril—systemic scleroderma	0.000215	0.000528	CcSEcCtD
Oxcarbazepine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000215	0.000527	CcSEcCtD
Oxcarbazepine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000215	0.000527	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000526	CcSEcCtD
Oxcarbazepine—Asthma—Methotrexate—systemic scleroderma	0.000213	0.000524	CcSEcCtD
Oxcarbazepine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000522	CcSEcCtD
Oxcarbazepine—Decreased appetite—Lisinopril—systemic scleroderma	0.000213	0.000522	CcSEcCtD
Oxcarbazepine—Eosinophilia—Methotrexate—systemic scleroderma	0.000211	0.000519	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000211	0.000518	CcSEcCtD
Oxcarbazepine—Fatigue—Lisinopril—systemic scleroderma	0.000211	0.000517	CcSEcCtD
Oxcarbazepine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000517	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000516	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000515	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00021	0.000514	CcSEcCtD
Oxcarbazepine—Pancreatitis—Methotrexate—systemic scleroderma	0.000209	0.000513	CcSEcCtD
Oxcarbazepine—Constipation—Lisinopril—systemic scleroderma	0.000209	0.000513	CcSEcCtD
Oxcarbazepine—Pain—Lisinopril—systemic scleroderma	0.000209	0.000513	CcSEcCtD
Oxcarbazepine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000209	0.000513	CcSEcCtD
Oxcarbazepine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000208	0.000511	CcSEcCtD
Oxcarbazepine—Bradycardia—Prednisone—systemic scleroderma	0.000208	0.000511	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000207	0.000508	CcSEcCtD
Oxcarbazepine—Diarrhoea—Azathioprine—systemic scleroderma	0.000206	0.000506	CcSEcCtD
Oxcarbazepine—Nausea—Captopril—systemic scleroderma	0.000205	0.000503	CcSEcCtD
Oxcarbazepine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000501	CcSEcCtD
Oxcarbazepine—Asthenia—Leflunomide—systemic scleroderma	0.000204	0.000501	CcSEcCtD
Oxcarbazepine—Pancytopenia—Methotrexate—systemic scleroderma	0.000203	0.000497	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000202	0.000494	CcSEcCtD
Oxcarbazepine—Pruritus—Leflunomide—systemic scleroderma	0.000201	0.000494	CcSEcCtD
Oxcarbazepine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000491	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.0002	0.000491	CcSEcCtD
Oxcarbazepine—Dysuria—Methotrexate—systemic scleroderma	0.0002	0.00049	CcSEcCtD
Oxcarbazepine—Neutropenia—Methotrexate—systemic scleroderma	0.0002	0.00049	CcSEcCtD
Oxcarbazepine—Dizziness—Azathioprine—systemic scleroderma	0.000199	0.000489	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000198	0.000487	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000479	CcSEcCtD
Oxcarbazepine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000195	0.000478	CcSEcCtD
Oxcarbazepine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000195	0.000478	CcSEcCtD
Oxcarbazepine—Diarrhoea—Leflunomide—systemic scleroderma	0.000195	0.000478	CcSEcCtD
Oxcarbazepine—Urticaria—Lisinopril—systemic scleroderma	0.000194	0.000477	CcSEcCtD
Oxcarbazepine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000476	CcSEcCtD
Oxcarbazepine—Abdominal pain—Lisinopril—systemic scleroderma	0.000193	0.000474	CcSEcCtD
Oxcarbazepine—Body temperature increased—Lisinopril—systemic scleroderma	0.000193	0.000474	CcSEcCtD
Oxcarbazepine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000192	0.000471	CcSEcCtD
Oxcarbazepine—Vomiting—Azathioprine—systemic scleroderma	0.000192	0.00047	CcSEcCtD
Oxcarbazepine—Pneumonia—Methotrexate—systemic scleroderma	0.000191	0.00047	CcSEcCtD
Oxcarbazepine—Eye disorder—Prednisone—systemic scleroderma	0.000191	0.000469	CcSEcCtD
Oxcarbazepine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000469	CcSEcCtD
Oxcarbazepine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00019	0.000467	CcSEcCtD
Oxcarbazepine—Infestation—Methotrexate—systemic scleroderma	0.00019	0.000467	CcSEcCtD
Oxcarbazepine—Infestation NOS—Methotrexate—systemic scleroderma	0.00019	0.000467	CcSEcCtD
Oxcarbazepine—Rash—Azathioprine—systemic scleroderma	0.00019	0.000466	CcSEcCtD
Oxcarbazepine—Dermatitis—Azathioprine—systemic scleroderma	0.00019	0.000466	CcSEcCtD
Oxcarbazepine—Flushing—Prednisone—systemic scleroderma	0.00019	0.000466	CcSEcCtD
Oxcarbazepine—Headache—Azathioprine—systemic scleroderma	0.000189	0.000463	CcSEcCtD
Oxcarbazepine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000189	0.000463	CcSEcCtD
Oxcarbazepine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000189	0.000463	CcSEcCtD
Oxcarbazepine—Dizziness—Leflunomide—systemic scleroderma	0.000188	0.000462	CcSEcCtD
Oxcarbazepine—Renal failure—Methotrexate—systemic scleroderma	0.000187	0.000459	CcSEcCtD
Oxcarbazepine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000186	0.000457	CcSEcCtD
Oxcarbazepine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000186	0.000456	CcSEcCtD
Oxcarbazepine—Stomatitis—Methotrexate—systemic scleroderma	0.000186	0.000455	CcSEcCtD
Oxcarbazepine—Angiopathy—Prednisone—systemic scleroderma	0.000185	0.000455	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000454	CcSEcCtD
Oxcarbazepine—Immune system disorder—Prednisone—systemic scleroderma	0.000185	0.000453	CcSEcCtD
Oxcarbazepine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000183	0.00045	CcSEcCtD
Oxcarbazepine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000183	0.00045	CcSEcCtD
Oxcarbazepine—Arrhythmia—Prednisone—systemic scleroderma	0.000183	0.000448	CcSEcCtD
Oxcarbazepine—Haematuria—Methotrexate—systemic scleroderma	0.000181	0.000445	CcSEcCtD
Oxcarbazepine—Vomiting—Leflunomide—systemic scleroderma	0.000181	0.000444	CcSEcCtD
Oxcarbazepine—Alopecia—Prednisone—systemic scleroderma	0.000181	0.000443	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00018	0.000442	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00018	0.000442	CcSEcCtD
Oxcarbazepine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00018	0.000441	CcSEcCtD
Oxcarbazepine—Epistaxis—Methotrexate—systemic scleroderma	0.00018	0.00044	CcSEcCtD
Oxcarbazepine—Rash—Leflunomide—systemic scleroderma	0.000179	0.00044	CcSEcCtD
Oxcarbazepine—Dermatitis—Leflunomide—systemic scleroderma	0.000179	0.00044	CcSEcCtD
Oxcarbazepine—Mental disorder—Prednisone—systemic scleroderma	0.000179	0.000439	CcSEcCtD
Oxcarbazepine—Nausea—Azathioprine—systemic scleroderma	0.000179	0.000439	CcSEcCtD
Oxcarbazepine—Headache—Leflunomide—systemic scleroderma	0.000178	0.000437	CcSEcCtD
Oxcarbazepine—Malnutrition—Prednisone—systemic scleroderma	0.000178	0.000437	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000178	0.000436	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000433	CcSEcCtD
Oxcarbazepine—Asthenia—Lisinopril—systemic scleroderma	0.000175	0.000431	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000175	0.00043	CcSEcCtD
Oxcarbazepine—Pruritus—Lisinopril—systemic scleroderma	0.000173	0.000425	CcSEcCtD
Oxcarbazepine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000173	0.000424	CcSEcCtD
Oxcarbazepine—Rash—Mycophenolic acid—systemic scleroderma	0.000171	0.00042	CcSEcCtD
Oxcarbazepine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000171	0.00042	CcSEcCtD
Oxcarbazepine—Hepatitis—Methotrexate—systemic scleroderma	0.000171	0.000419	CcSEcCtD
Oxcarbazepine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000418	CcSEcCtD
Oxcarbazepine—Headache—Mycophenolic acid—systemic scleroderma	0.00017	0.000417	CcSEcCtD
Oxcarbazepine—Pharyngitis—Methotrexate—systemic scleroderma	0.00017	0.000416	CcSEcCtD
Oxcarbazepine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000416	CcSEcCtD
Oxcarbazepine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000416	CcSEcCtD
Oxcarbazepine—Nausea—Leflunomide—systemic scleroderma	0.000169	0.000415	CcSEcCtD
Oxcarbazepine—Vision blurred—Prednisone—systemic scleroderma	0.000168	0.000412	CcSEcCtD
Oxcarbazepine—Diarrhoea—Lisinopril—systemic scleroderma	0.000167	0.000411	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000165	0.000405	CcSEcCtD
Oxcarbazepine—Visual impairment—Methotrexate—systemic scleroderma	0.000165	0.000404	CcSEcCtD
Oxcarbazepine—Agitation—Prednisone—systemic scleroderma	0.000164	0.000401	CcSEcCtD
Oxcarbazepine—Angioedema—Prednisone—systemic scleroderma	0.000163	0.000399	CcSEcCtD
Oxcarbazepine—Dizziness—Lisinopril—systemic scleroderma	0.000162	0.000397	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000162	0.000396	CcSEcCtD
Oxcarbazepine—Nausea—Mycophenolic acid—systemic scleroderma	0.000161	0.000396	CcSEcCtD
Oxcarbazepine—Malaise—Prednisone—systemic scleroderma	0.00016	0.000394	CcSEcCtD
Oxcarbazepine—Vertigo—Prednisone—systemic scleroderma	0.00016	0.000392	CcSEcCtD
Oxcarbazepine—Eye disorder—Methotrexate—systemic scleroderma	0.00016	0.000392	CcSEcCtD
Oxcarbazepine—Syncope—Prednisone—systemic scleroderma	0.00016	0.000392	CcSEcCtD
Oxcarbazepine—Tinnitus—Methotrexate—systemic scleroderma	0.000159	0.000391	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000159	0.000389	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000387	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Prednisone—systemic scleroderma	0.000156	0.000384	CcSEcCtD
Oxcarbazepine—Vomiting—Lisinopril—systemic scleroderma	0.000155	0.000382	CcSEcCtD
Oxcarbazepine—Angiopathy—Methotrexate—systemic scleroderma	0.000155	0.00038	CcSEcCtD
Oxcarbazepine—Immune system disorder—Methotrexate—systemic scleroderma	0.000154	0.000379	CcSEcCtD
Oxcarbazepine—Rash—Lisinopril—systemic scleroderma	0.000154	0.000378	CcSEcCtD
Oxcarbazepine—Convulsion—Prednisone—systemic scleroderma	0.000154	0.000378	CcSEcCtD
Oxcarbazepine—Dermatitis—Lisinopril—systemic scleroderma	0.000154	0.000378	CcSEcCtD
Oxcarbazepine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000377	CcSEcCtD
Oxcarbazepine—Hypertension—Prednisone—systemic scleroderma	0.000154	0.000377	CcSEcCtD
Oxcarbazepine—Chills—Methotrexate—systemic scleroderma	0.000153	0.000376	CcSEcCtD
Oxcarbazepine—Headache—Lisinopril—systemic scleroderma	0.000153	0.000376	CcSEcCtD
Oxcarbazepine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000372	CcSEcCtD
Oxcarbazepine—Arthralgia—Prednisone—systemic scleroderma	0.000152	0.000372	CcSEcCtD
Oxcarbazepine—Myalgia—Prednisone—systemic scleroderma	0.000152	0.000372	CcSEcCtD
Oxcarbazepine—Anxiety—Prednisone—systemic scleroderma	0.000151	0.00037	CcSEcCtD
Oxcarbazepine—Alopecia—Methotrexate—systemic scleroderma	0.000151	0.00037	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00015	0.000369	CcSEcCtD
Oxcarbazepine—Discomfort—Prednisone—systemic scleroderma	0.00015	0.000367	CcSEcCtD
Oxcarbazepine—Mental disorder—Methotrexate—systemic scleroderma	0.00015	0.000367	CcSEcCtD
Oxcarbazepine—Malnutrition—Methotrexate—systemic scleroderma	0.000149	0.000365	CcSEcCtD
Oxcarbazepine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000147	0.00036	CcSEcCtD
Oxcarbazepine—Dysgeusia—Methotrexate—systemic scleroderma	0.000146	0.000357	CcSEcCtD
Oxcarbazepine—Nausea—Lisinopril—systemic scleroderma	0.000145	0.000356	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000145	0.000356	CcSEcCtD
Oxcarbazepine—Infection—Prednisone—systemic scleroderma	0.000144	0.000354	CcSEcCtD
Oxcarbazepine—Back pain—Methotrexate—systemic scleroderma	0.000144	0.000353	CcSEcCtD
Oxcarbazepine—Shock—Prednisone—systemic scleroderma	0.000143	0.000351	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Prednisone—systemic scleroderma	0.000142	0.000349	CcSEcCtD
Oxcarbazepine—Tachycardia—Prednisone—systemic scleroderma	0.000142	0.000348	CcSEcCtD
Oxcarbazepine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000348	CcSEcCtD
Oxcarbazepine—Skin disorder—Prednisone—systemic scleroderma	0.000141	0.000346	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00014	0.000345	CcSEcCtD
Oxcarbazepine—Vision blurred—Methotrexate—systemic scleroderma	0.00014	0.000344	CcSEcCtD
Oxcarbazepine—Anorexia—Prednisone—systemic scleroderma	0.000138	0.00034	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000138	0.000339	CcSEcCtD
Oxcarbazepine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000334	CcSEcCtD
Oxcarbazepine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000331	CcSEcCtD
Oxcarbazepine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000331	CcSEcCtD
Oxcarbazepine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000329	CcSEcCtD
Oxcarbazepine—Malaise—Methotrexate—systemic scleroderma	0.000134	0.000329	CcSEcCtD
Oxcarbazepine—Vertigo—Methotrexate—systemic scleroderma	0.000134	0.000328	CcSEcCtD
Oxcarbazepine—Leukopenia—Methotrexate—systemic scleroderma	0.000133	0.000327	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000132	0.000325	CcSEcCtD
Oxcarbazepine—Insomnia—Prednisone—systemic scleroderma	0.000131	0.000322	CcSEcCtD
Oxcarbazepine—Cough—Methotrexate—systemic scleroderma	0.00013	0.000318	CcSEcCtD
Oxcarbazepine—Convulsion—Methotrexate—systemic scleroderma	0.000129	0.000316	CcSEcCtD
Oxcarbazepine—Dyspepsia—Prednisone—systemic scleroderma	0.000128	0.000314	CcSEcCtD
Oxcarbazepine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000312	CcSEcCtD
Oxcarbazepine—Chest pain—Methotrexate—systemic scleroderma	0.000127	0.000311	CcSEcCtD
Oxcarbazepine—Arthralgia—Methotrexate—systemic scleroderma	0.000127	0.000311	CcSEcCtD
Oxcarbazepine—Myalgia—Methotrexate—systemic scleroderma	0.000127	0.000311	CcSEcCtD
Oxcarbazepine—Decreased appetite—Prednisone—systemic scleroderma	0.000126	0.00031	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000126	0.000309	CcSEcCtD
Oxcarbazepine—Fatigue—Prednisone—systemic scleroderma	0.000125	0.000307	CcSEcCtD
Oxcarbazepine—Discomfort—Methotrexate—systemic scleroderma	0.000125	0.000307	CcSEcCtD
Oxcarbazepine—Constipation—Prednisone—systemic scleroderma	0.000124	0.000305	CcSEcCtD
Oxcarbazepine—Confusional state—Methotrexate—systemic scleroderma	0.000122	0.0003	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000121	0.000298	CcSEcCtD
Oxcarbazepine—Infection—Methotrexate—systemic scleroderma	0.000121	0.000296	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Prednisone—systemic scleroderma	0.00012	0.000294	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000119	0.000292	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000119	0.000292	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000119	0.000291	CcSEcCtD
Oxcarbazepine—Skin disorder—Methotrexate—systemic scleroderma	0.000118	0.000289	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000117	0.000288	CcSEcCtD
Oxcarbazepine—Anorexia—Methotrexate—systemic scleroderma	0.000116	0.000284	CcSEcCtD
Oxcarbazepine—Urticaria—Prednisone—systemic scleroderma	0.000115	0.000283	CcSEcCtD
Oxcarbazepine—Abdominal pain—Prednisone—systemic scleroderma	0.000115	0.000282	CcSEcCtD
Oxcarbazepine—Body temperature increased—Prednisone—systemic scleroderma	0.000115	0.000282	CcSEcCtD
Oxcarbazepine—Hypotension—Methotrexate—systemic scleroderma	0.000113	0.000278	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000111	0.000271	CcSEcCtD
Oxcarbazepine—Insomnia—Methotrexate—systemic scleroderma	0.00011	0.000269	CcSEcCtD
Oxcarbazepine—Dyspnoea—Methotrexate—systemic scleroderma	0.000108	0.000266	CcSEcCtD
Oxcarbazepine—Somnolence—Methotrexate—systemic scleroderma	0.000108	0.000265	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Prednisone—systemic scleroderma	0.000107	0.000263	CcSEcCtD
Oxcarbazepine—Dyspepsia—Methotrexate—systemic scleroderma	0.000107	0.000262	CcSEcCtD
Oxcarbazepine—Decreased appetite—Methotrexate—systemic scleroderma	0.000106	0.000259	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000105	0.000257	CcSEcCtD
Oxcarbazepine—Fatigue—Methotrexate—systemic scleroderma	0.000105	0.000257	CcSEcCtD
Oxcarbazepine—Asthenia—Prednisone—systemic scleroderma	0.000104	0.000256	CcSEcCtD
Oxcarbazepine—Pain—Methotrexate—systemic scleroderma	0.000104	0.000255	CcSEcCtD
Oxcarbazepine—Pruritus—Prednisone—systemic scleroderma	0.000103	0.000252	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Methotrexate—systemic scleroderma	0.0001	0.000245	CcSEcCtD
Oxcarbazepine—Diarrhoea—Prednisone—systemic scleroderma	9.94e-05	0.000244	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Methotrexate—systemic scleroderma	9.93e-05	0.000244	CcSEcCtD
Oxcarbazepine—Urticaria—Methotrexate—systemic scleroderma	9.64e-05	0.000237	CcSEcCtD
Oxcarbazepine—Dizziness—Prednisone—systemic scleroderma	9.6e-05	0.000236	CcSEcCtD
Oxcarbazepine—Body temperature increased—Methotrexate—systemic scleroderma	9.6e-05	0.000235	CcSEcCtD
Oxcarbazepine—Abdominal pain—Methotrexate—systemic scleroderma	9.6e-05	0.000235	CcSEcCtD
Oxcarbazepine—Vomiting—Prednisone—systemic scleroderma	9.24e-05	0.000227	CcSEcCtD
Oxcarbazepine—Rash—Prednisone—systemic scleroderma	9.16e-05	0.000225	CcSEcCtD
Oxcarbazepine—Dermatitis—Prednisone—systemic scleroderma	9.15e-05	0.000224	CcSEcCtD
Oxcarbazepine—Headache—Prednisone—systemic scleroderma	9.1e-05	0.000223	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Methotrexate—systemic scleroderma	8.94e-05	0.000219	CcSEcCtD
Oxcarbazepine—Asthenia—Methotrexate—systemic scleroderma	8.71e-05	0.000214	CcSEcCtD
Oxcarbazepine—Nausea—Prednisone—systemic scleroderma	8.63e-05	0.000212	CcSEcCtD
Oxcarbazepine—Pruritus—Methotrexate—systemic scleroderma	8.59e-05	0.000211	CcSEcCtD
Oxcarbazepine—Diarrhoea—Methotrexate—systemic scleroderma	8.31e-05	0.000204	CcSEcCtD
Oxcarbazepine—Dizziness—Methotrexate—systemic scleroderma	8.03e-05	0.000197	CcSEcCtD
Oxcarbazepine—Vomiting—Methotrexate—systemic scleroderma	7.72e-05	0.000189	CcSEcCtD
Oxcarbazepine—Rash—Methotrexate—systemic scleroderma	7.65e-05	0.000188	CcSEcCtD
Oxcarbazepine—Dermatitis—Methotrexate—systemic scleroderma	7.65e-05	0.000188	CcSEcCtD
Oxcarbazepine—Headache—Methotrexate—systemic scleroderma	7.6e-05	0.000187	CcSEcCtD
Oxcarbazepine—Nausea—Methotrexate—systemic scleroderma	7.21e-05	0.000177	CcSEcCtD
